世界の肺がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lung Cancer Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4445
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、標的療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・肺がん治療の市場動向
・企業の競争状況、市場シェア
・肺がん治療の種類別市場規模と予測2016-2027（放射線療法、化学療法、標的療法、免疫療法）
・肺がん治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・肺がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・肺がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・肺がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・肺がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・肺がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Menarini、Pfizer、Roche、Merck、AstraZeneca、Sanofi-Aventis、Eli Lilly and Company、Abbott、Akebia Therapeutics、Agennix AG）
・結論

Market Analysis and Insights: Global Lung Cancer Therapy Market
The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Therapy market.

Global Lung Cancer Therapy Scope and Market Size
Lung Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Radiation Therapy
Chemotherapy
Targeted Therapies
Immunotherapy

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Menarini
Pfizer
Roche
Merck
AstraZeneca
Sanofi-Aventis
Eli Lilly and Company
Abbott
Akebia Therapeutics
Agennix AG

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Targeted Therapies
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Lung Cancer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Therapy Market Perspective (2016-2027)
2.2 Lung Cancer Therapy Growth Trends by Regions
2.2.1 Lung Cancer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Therapy Industry Dynamic
2.3.1 Lung Cancer Therapy Market Trends
2.3.2 Lung Cancer Therapy Market Drivers
2.3.3 Lung Cancer Therapy Market Challenges
2.3.4 Lung Cancer Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Therapy Players by Revenue
3.1.1 Global Top Lung Cancer Therapy Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Therapy Revenue
3.4 Global Lung Cancer Therapy Market Concentration Ratio
3.4.1 Global Lung Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapy Revenue in 2020
3.5 Lung Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Lung Cancer Therapy Product Solution and Service
3.7 Date of Enter into Lung Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Therapy Breakdown Data by Type
4.1 Global Lung Cancer Therapy Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Therapy Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Therapy Breakdown Data by Application
5.1 Global Lung Cancer Therapy Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Therapy Market Size (2016-2027)
6.2 North America Lung Cancer Therapy Market Size by Type
6.2.1 North America Lung Cancer Therapy Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Therapy Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Therapy Market Size by Type (2016-2027)
6.3 North America Lung Cancer Therapy Market Size by Application
6.3.1 North America Lung Cancer Therapy Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Therapy Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Therapy Market Size by Application (2016-2027)
6.4 North America Lung Cancer Therapy Market Size by Country
6.4.1 North America Lung Cancer Therapy Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lung Cancer Therapy Market Size (2016-2027)
7.2 Europe Lung Cancer Therapy Market Size by Type
7.2.1 Europe Lung Cancer Therapy Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Therapy Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Therapy Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Therapy Market Size by Application
7.3.1 Europe Lung Cancer Therapy Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Therapy Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Therapy Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Therapy Market Size by Country
7.4.1 Europe Lung Cancer Therapy Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Therapy Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Therapy Market Size (2016-2027)
9.2 Latin America Lung Cancer Therapy Market Size by Type
9.2.1 Latin America Lung Cancer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Therapy Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Therapy Market Size by Application
9.3.1 Latin America Lung Cancer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Therapy Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Therapy Market Size by Country
9.4.1 Latin America Lung Cancer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Therapy Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Lung Cancer Therapy Introduction
11.1.4 GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Menarini
11.2.1 Menarini Company Details
11.2.2 Menarini Business Overview
11.2.3 Menarini Lung Cancer Therapy Introduction
11.2.4 Menarini Revenue in Lung Cancer Therapy Business (2016-2021)
11.2.5 Menarini Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Lung Cancer Therapy Introduction
11.3.4 Pfizer Revenue in Lung Cancer Therapy Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Lung Cancer Therapy Introduction
11.4.4 Roche Revenue in Lung Cancer Therapy Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Lung Cancer Therapy Introduction
11.5.4 Merck Revenue in Lung Cancer Therapy Business (2016-2021)
11.5.5 Merck Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Lung Cancer Therapy Introduction
11.6.4 AstraZeneca Revenue in Lung Cancer Therapy Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Details
11.7.2 Sanofi-Aventis Business Overview
11.7.3 Sanofi-Aventis Lung Cancer Therapy Introduction
11.7.4 Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2016-2021)
11.7.5 Sanofi-Aventis Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Lung Cancer Therapy Introduction
11.8.4 Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Lung Cancer Therapy Introduction
11.9.4 Abbott Revenue in Lung Cancer Therapy Business (2016-2021)
11.9.5 Abbott Recent Development
11.10 Akebia Therapeutics
11.10.1 Akebia Therapeutics Company Details
11.10.2 Akebia Therapeutics Business Overview
11.10.3 Akebia Therapeutics Lung Cancer Therapy Introduction
11.10.4 Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2016-2021)
11.10.5 Akebia Therapeutics Recent Development
11.11 Agennix AG
11.11.1 Agennix AG Company Details
11.11.2 Agennix AG Business Overview
11.11.3 Agennix AG Lung Cancer Therapy Introduction
11.11.4 Agennix AG Revenue in Lung Cancer Therapy Business (2016-2021)
11.11.5 Agennix AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Cancer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Targeted Therapies
Table 5. Key Players of Immunotherapy
Table 6. Global Lung Cancer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lung Cancer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lung Cancer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lung Cancer Therapy Market Share by Regions (2016-2021)
Table 10. Global Lung Cancer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lung Cancer Therapy Market Share by Regions (2022-2027)
Table 12. Lung Cancer Therapy Market Trends
Table 13. Lung Cancer Therapy Market Drivers
Table 14. Lung Cancer Therapy Market Challenges
Table 15. Lung Cancer Therapy Market Restraints
Table 16. Global Lung Cancer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lung Cancer Therapy Market Share by Players (2016-2021)
Table 18. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapy as of 2020)
Table 19. Ranking of Global Top Lung Cancer Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lung Cancer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lung Cancer Therapy Product Solution and Service
Table 23. Date of Enter into Lung Cancer Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lung Cancer Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Lung Cancer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lung Cancer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lung Cancer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lung Cancer Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Lung Cancer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lung Cancer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lung Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lung Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lung Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lung Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lung Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lung Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lung Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lung Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lung Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lung Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lung Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lung Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lung Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lung Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lung Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lung Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lung Cancer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lung Cancer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lung Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lung Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lung Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lung Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lung Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lung Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lung Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lung Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lung Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lung Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lung Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lung Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Lung Cancer Therapy Product
Table 66. GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Menarini Company Details
Table 69. Menarini Business Overview
Table 70. Menarini Lung Cancer Therapy Product
Table 71. Menarini Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 72. Menarini Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Lung Cancer Therapy Product
Table 76. Pfizer Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Lung Cancer Therapy Product
Table 81. Roche Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Lung Cancer Therapy Product
Table 86. Merck Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Lung Cancer Therapy Product
Table 91. AstraZeneca Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 92. AstraZeneca Recent Development
Table 93. Sanofi-Aventis Company Details
Table 94. Sanofi-Aventis Business Overview
Table 95. Sanofi-Aventis Lung Cancer Therapy Product
Table 96. Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 97. Sanofi-Aventis Recent Development
Table 98. Eli Lilly and Company Company Details
Table 99. Eli Lilly and Company Business Overview
Table 100. Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 101. Eli Lilly and Company Recent Development
Table 102. Abbott Company Details
Table 103. Abbott Business Overview
Table 104. Abbott Lung Cancer Therapy Product
Table 105. Abbott Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 106. Abbott Recent Development
Table 107. Akebia Therapeutics Company Details
Table 108. Akebia Therapeutics Business Overview
Table 109. Akebia Therapeutics Lung Cancer Therapy Product
Table 110. Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 111. Akebia Therapeutics Recent Development
Table 112. Agennix AG Company Details
Table 113. Agennix AG Business Overview
Table 114. Agennix AG Lung Cancer Therapy Product
Table 115. Agennix AG Revenue in Lung Cancer Therapy Business (2016-2021) & (US$ Million)
Table 116. Agennix AG Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Therapy Market Share by Type: 2020 VS 2027
Figure 2. Radiation Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapies Features
Figure 5. Immunotherapy Features
Figure 6. Global Lung Cancer Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Lung Cancer Therapy Report Years Considered
Figure 11. Global Lung Cancer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lung Cancer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lung Cancer Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Lung Cancer Therapy Market Share by Regions (2022-2027)
Figure 15. Global Lung Cancer Therapy Market Share by Players in 2020
Figure 16. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2020
Figure 18. Global Lung Cancer Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Lung Cancer Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lung Cancer Therapy Market Share by Type (2016-2027)
Figure 22. North America Lung Cancer Therapy Market Share by Application (2016-2027)
Figure 23. North America Lung Cancer Therapy Market Share by Country (2016-2027)
Figure 24. United States Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lung Cancer Therapy Market Share by Type (2016-2027)
Figure 28. Europe Lung Cancer Therapy Market Share by Application (2016-2027)
Figure 29. Europe Lung Cancer Therapy Market Share by Country (2016-2027)
Figure 30. Germany Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lung Cancer Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lung Cancer Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lung Cancer Therapy Market Share by Region (2016-2027)
Figure 40. China Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lung Cancer Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Lung Cancer Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Lung Cancer Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lung Cancer Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lung Cancer Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lung Cancer Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lung Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 60. Menarini Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 65. Sanofi-Aventis Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 67. Abbott Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 68. Akebia Therapeutics Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 69. Agennix AG Revenue Growth Rate in Lung Cancer Therapy Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4444 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法、化学療法、放射線療法、その他）、用途別市場規模（非小細胞肺がん（NSCLC）、小細胞肺がん（SCLC））、主要地域別市場...

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5895 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ...

世界の肺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4443 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、肺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界のALK陽性肺がん治療市場規模・現状・予測（2021年-2027年）

Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5075 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ALK陽性肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリゾチニブ、アレクチニブ、セリチニブ、ブリグチニブ、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、ア...

世界のがん点滴療法市場規模・現状・予測（2021年-2027年）

Global Cancer Infusion Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3956 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、がん点滴療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬局、在宅医療機関、その他）、用途別市場規模（がん、慢性疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年）

Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3955 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、がんホルモン療法剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他）、用途別市場規模（乳がん、前立腺がん）、主要地域...

世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年）

Global Gene Detection for Individualized Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4246 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遺伝子検出用個別化癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状発生前検査）、用途別市場規模（病院、クリニック、診断センタ...

世界のCD抗原がん治療市場規模・現状・予測（2021年-2027年）

Global CD Antigen Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3982 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、CD抗原がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、皮下、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の腎臓癌治療市場規模・現状・予測（2021年-2027年）

Global Kidney Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5821 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、腎臓癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、mTOR阻害剤、キナーゼ阻害剤、その他）、用途別市場規模（腎細胞癌（RCC）、移行上皮癌（TCC））、主要地域別市場規模（...

世界の陽子線治療市場規模・現状・予測（2021年-2027年）

Global Proton Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5321 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、陽子線治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（電子ビーム、陽子ビーム、中性子ビーム、炭素イオンビーム、アルファ粒子ビーム、ベータ粒子ビーム）、用途別市場規模（小児がん、骨・軟部がん、前立腺...

世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…
世界のがん点滴療法市場規模・現状・予測（2021年-2027年） Cancer treatments often require infusion treatments, like chemotherapy. Market Analysis and Insights: Global Cancer Infusion Therapy Market The global Cancer Infusion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
世界の小分子標的治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Therapy Market The global Small Molecule Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…